Genmab A (GMAB) Cash & Current Investments: 2018-2021
- Genmab A's Cash & Current Investments fell 33.95% to $245.4 million in Q2 2021 from the same period last year, while for Jun 2021 it was -$216.7 million, marking a year-over-year decrease of 109.03%. This contributed to the annual value of -$598.7 million for FY2020, which is 154.75% down from last year.
- According to the latest figures from Q2 2021, Genmab A's Cash & Current Investments is $245.4 million, which was up 140.99% from -$598.7 million recorded in Q4 2020.
- Over the past 5 years, Genmab A's Cash & Current Investments peaked at $371.6 million during Q2 2020, and registered a low of -$598.7 million during Q4 2020.
- In the last 3 years, Genmab A's Cash & Current Investments had a median value of -$172.89 in 2019 and averaged -$43.3 million.
- Data for Genmab A's Cash & Current Investments shows a peak YoY increase of 214,938,055.93% (in 2020) and a maximum YoY decrease of 154.75% (in 2020) over the last 5 years.
- Quarterly analysis of 4 years shows Genmab A's Cash & Current Investments stood at -$240.3 million in 2018, then grew by 2.17% to -$235.0 million in 2019, then crashed by 154.75% to -$598.7 million in 2020, then slumped by 33.95% to $245.4 million in 2021.
- Its Cash & Current Investments was $245.4 million in Q2 2021, compared to -$598.7 million in Q4 2020 and $371.6 million in Q2 2020.
